Alan Paul

ICFAI University, Tripura — India

Medicine · Health Sciences

23h-index6.3kcitations64works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Diagnosis and Treatment(18), Prostate Cancer Treatment and Research(17), Bladder and Urothelial Cancer Treatments(14), Urological Disorders and Treatments(5), Urinary and Genital Oncology Studies(5)

Publications61 total

Mononuclear Co(III) complex: Synthesis, characterization and molecular docking with multiple protein targets, and EGFR inhibition
Polyhedron·2025· 1 cited
Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer
New England Journal of Medicine·2023· 666 citedOpen Access
Patient-Reported Outcomes 12 Years after Localized Prostate Cancer Treatment
NEJM Evidence·2023· 87 citedOpen Access
Healthcare Monitoring for SCI Individuals: Learning Activities of Daily Living through a SlowFast Neural Network
2023 IEEE/SICE International Symposium on System Integration (SII)·2023· 6 citedOpen Access
Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment <scp>[ProtecT]</scp> study)
British Journal of Urology·2022· 82 citedOpen Access
Renal Transplantation and its Psychological Effects
Journal of Clinical & Experimental Nephrology·2021Open Access
Negative Food Effect of Danirixin: Use of PBPK Modelling to Explore the Effect of Formulation and Meal Type on Clinical PK
Pharmaceutical Research·2020· 12 cited
Modelling the lifetime cost-effectiveness of radical prostatectomy, radiotherapy and active monitoring for men with clinically localised prostate cancer from median 10-year outcomes in the ProtecT randomised trial
BMC Cancer·2020· 14 citedOpen Access
Strategies adopted by men to deal with uncertainty and anxiety when following an active surveillance/monitoring protocol for localised prostate cancer and implications for care: a longitudinal qualitative study embedded within the ProtecT trial
BMJ Open·2020· 17 citedOpen Access
Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT
Health Technology Assessment·2020· 47 citedOpen Access
The ProtecT randomised trial cost-effectiveness analysis comparing active monitoring, surgery, or radiotherapy for prostate cancer
British Journal of Cancer·2020· 19 citedOpen Access
Erratum to ‘Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received’ [European Urology 77 (2020) 320–330]
European Urology·2020Open Access
Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received
European Urology·2019· 147 citedOpen Access
Factors associated with trial recruitment, preferences, and treatments received were elucidated in a comprehensive cohort study
Journal of Clinical Epidemiology·2019· 9 citedOpen Access
Prevalencia y principales factores asociados a tuberculosis multidrogorresistente en pacientes hospitalizados en el pabellón de neumología del hospital nacional hipólito unanue, enero-diciembre 2018
Universidad Nacional Federico Villarreal·2019
A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial: the ProtecT prostate cancer trial
Journal of Clinical Epidemiology·2017· 20 citedOpen Access
Mortality Among Men with Advanced Prostate Cancer Excluded from the ProtecT Trial
European Urology·2016· 44 citedOpen Access
Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer
New England Journal of Medicine·2016· 1.3k citedOpen Access
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer
New England Journal of Medicine·2016· 2.6k citedOpen Access
Do prostate cancer nomograms give accurate information when applied to European patients?
Scandinavian Journal of Urology·2014· 20 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Freddie C. Hamdy(14), Jenny Donovan(14), J. Athene Lane(14), Prasad Bollina(14), Alan Doherty(14), Roger Kockelbergh(14), Howard Kynaston(14), Edward Rowe(14), David E. Neal(14), Chris Metcalfe(13), James W.F. Catto(13), David Gillatt(13), Derek J. Rosario(13), T. J. Peters(12), Emma L. Turner(12), Richard M. Martin(12), Vincent J. Gnanapragasam(12), Malcolm D. Mason(11), Michael Davis(11), Eleanor Walsh(11)